Exagen Inc expected to post a loss of 29 cents a share - Earnings Preview

Exagen

08/11/2024 16:25

* Exagen Inc  XGN.OQ   XGN.O  is expected to show a rise in
quarterly revenue when it reports  results on November 12 for
the period ending September 30 2024
    * The Vista California-based  company is expected to report
a
1.1% increase in revenue to $13.565 million from $13.42 million
a year ago, according to the mean estimate from 6 analysts,
based on LSEG data.
    * ​LSEG's mean analyst estimate for Exagen Inc is for a loss
of 29
cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Exagen Inc
is
$6.00​, above​ its last closing price of $2.60. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Jun. 30 2024  -0.34       -0.34      -0.16     Beat    53.6
 Mar. 31 2024  -0.36       -0.36      -0.19     Beat    47.5
 Dec. 31 2023  -0.40       -0.43      -0.31     Beat    28.5​
 Sep. 30 2023  -0.46       -0.47      -0.31     Beat    34
 ​​Jun.        -0.50       -0.49      -0.28     Beat    43.4
 30 2023                                                
 Mar. 31 2023  -0.57       -0.56      -0.44     Beat    21.7​
 Dec. 31 2022  -0.81       -0.78      -0.83     Missed  -6.4
 Sep. 30 2022  -0.73       -0.73      -0.47     Beat    35.6
 This summary was machine generated November 8 at 16:25 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)